ArticleSignal transduction and targeted therapy2022

Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents.

Xiaofeng Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.